Skip to content

Supplemental diagnostic methods of IgA nephropathy using morphological studies of urinary erythrocytes and tonsil biopsies in the patients with isolated hematuria.

Supplemental diagnostic methods of IgA nephropathy using morphological studies of urinary erythrocytes and tonsil biopsies in the patients with isolated hematuria. - Suuplemental diagnostic methods of IgA nephropathy using morphological studies of urinary erythrocytes and tonsil biopsies.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000003844
Enrollment
30
Registered
2010-06-30
Start date
2010-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematuria

Interventions

None listed

Sponsors

National Defense Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: continuous hematuria (URBC 5-9/HPF or more)

Exclusion criteria

Exclusion criteria: 1. proteinuria of 0.3g/gCr and/or 0.3g/day (1+ by test tape) or more 2. renal biopsy was already done 3. presence of urological abnormalities by abdominal X-ray, abdominal echo, or urinary cytologic examination 4. serum creatinine 2.0mg/dl or more

Design outcomes

Primary

MeasureTime frame
The correspondence of diagnosis of IgA nephropathy by renal biopsy to the result of supplemental diagnostic methods using morphological study of urinary erythrocytes and tonsil biopsy

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026